Irazu Oncology
Irazu Oncology is a startup headquartered in Baltimore, United States, founded in 2022. It has raised at least $2.6m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Irazu Oncology has raised at least $2.6m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Irazu Oncology sits inside the Washington DC and Maryland R&D ecosystem in the Global R&D Labs Directory.
Other startups in Baltimore
- CraniUS
- Elixirgen Therapeutics
- Impruvon
- Infinity Bio
- ManaT Bio
- Mohawk Games
- Neurava
- Pearl Diagnostics
- Porter Cares
- Postr Technologies
- SudShare
Related
- Innovation profile of Baltimore
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Irazu Oncology do?
Irazu Oncology is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Irazu Oncology raised?
At least $2.6m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Irazu Oncology based?
Irazu Oncology is headquartered in Baltimore, United States.
When was Irazu Oncology founded?
Irazu Oncology was founded in 2022.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.